A novel treatment for Leber’s Hereditary Optic Neuropathy (LHON), a rare genetic disease that can lead to sudden loss of vision, has been approved for NHS patients following a successful clinical trial co-led by UCL and Moorfields researchers.
This article was originally published on MedicalXpress.com